Therapeutic drugs for SARS-CoV-2 treatment: Current state and perspective

The disease caused by viral pneumonia called severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2) declared by the World Health Organization is a global pandemic that the world has witnessed since the last Ebola epidemic, SARS and MERS viruses. Many chemical compounds with antiviral acti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Immunopharmacol
Main Authors: Bolarin, Joshua Adedeji, Oluwatoyosi, Mercy Adaramodu, Orege, Joshua Iseoluwa, Ayeni, Emmanuel Ayodeji, Ibrahim, Yusuf Ajibola, Adeyemi, Sherif Babatunde, Tiamiyu, Bashir Bolaji, Gbadegesin, Lanre Anthony, Akinyemi, Toluwanimi Oluwadara, Odoh, Chuks Kenneth, Umeobi, Happiness Ijeoma, Adeoye, Adenike Bernice-Eloise
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier B.V. 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7691844/
https://ncbi.nlm.nih.gov/pubmed/33302035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2020.107228
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados